Medicine Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
LATEST RECOMMENDATION
Roland Seifert, Medical School of Hannover, Germany. F1000 Pharmacology & Drug Discovery
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
7 Recommendations, most recent by
Dominique Ferrandon, Institut de Biologie Moléculaire et Cellulaire du CNRS, France. F1000 Immunology
- Good for Teaching
- New Finding
- Technical Advance
Past 7 Days
386
New Recommendations
106,867 total
165
New Articles Recommended
38,642 total
Past 30 Days
-
167Articles Classified As Controversial8,003 total
-
82Articles Classified As Novel Drug Target1,669 total
-
9Articles Classified As Changes Clinical Practice3,958 total
-
109Articles Classified As Review / Commentary5,611 total
-
355Articles Classified As Confirmation27,023 total
-
107Articles Classified As Technical Advance7,021 total
-
746Articles Classified As New Finding50,326 total
-
209Articles Classified As Interesting Hypothesis14,417 total
-
358Articles Classified As Good for Teaching3,404 total
-
24Articles Classified As Refutation1,608 total
-
489Articles Classified As Clinical Trial27,430 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
